THE DOSE OF MARROW STEM-CELLS INFUSED IS CRITICAL TO REDUCE TRANSPLANT-RELATED MORTALITY (TRM), FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN PATIENTS WITH ACUTE-LEUKEMIA (AL), USING MARROW PURGED BY MAFOSFAMIDE

Citation
Nc. Gorin et al., THE DOSE OF MARROW STEM-CELLS INFUSED IS CRITICAL TO REDUCE TRANSPLANT-RELATED MORTALITY (TRM), FOR AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN PATIENTS WITH ACUTE-LEUKEMIA (AL), USING MARROW PURGED BY MAFOSFAMIDE, Bone marrow transplantation, 21, 1998, pp. 10-10
Citations number
NO
Categorie Soggetti
Hematology,Oncology,Immunology,Transplantation
Journal title
ISSN journal
02683369
Volume
21
Year of publication
1998
Supplement
1
Pages
10 - 10
Database
ISI
SICI code
0268-3369(1998)21:<10:TDOMSI>2.0.ZU;2-A